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Dear Sir,
We read with interest the recent publication by Wei et al. 
[1], investigating the microbiome of the reproductive 
tract in regular cycling women (N = 50), who underwent 
laparoscopic surgery for benign gynecological tumors. 
The study is in fact a re-analysis of a prior study [2], using 
a case control design to compare the microbiome of vari-
ous anatomical sites along the reproductive tract; 16S 
rRNA gene sequencing was performed in women with 
verified endometriosis (staging as defined by American 
Fertility Association) versus controls with no endome-
triosis. The authors conclude that endometriosis patients 
have an altered endometrial and peritoneal fluid micro-
biota containing “signature species” as compared to 
non-endometriosis controls. However, before the above-
mentioned conclusion can be drawn, we aim to highlight 
important limitations which are key elements of good 
practice generally relevant to low biomass microbiota 
studies.
First, transparency and replicability are key issues—
also in microbiome research [3]. Thus, the authors should 
be encouraged to make available the specifics of the data 
analysis, including the bioinformatic pipeline from raw 
sequences to species annotation, and also to clarify how 
figures were constructed. As a matter of fact, it seems 
that Fig. 1 only shows genus annotation and in Fig. 2 only 
one bacterium—Lactobacillus iners—is identified to the 
species level. Metadata is also lacking about the cases and 
controls.
Second, it is important to make available results from 
negative controls at all major steps through analysis. 
This would increase the confidence in the low abundant 
microbiota results being a true biological signal and not a 
false positive signal—e.g. from contamination. Thus, Wei 
et al. ought to provide microbiome results on the negative 
controls, e.g. a comparison in terms of sequencing depth 
and “signature OTUs” in the negative controls compared 
to samples from especially the low bio-mass sites such as 
the endometrium and the peritoneal fluid. In fact, more 
than 50% of the “signature OTUs” in Fig. 2 of the endo-
metrial and peritoneal fluid, respectively, are well-known 
contaminants from sequenced blank controls [4, 5].
Third, when choosing to report new diagnostic/strati-
fication methods, it is important to clearly state what 
defines them. Wei et  al. stratified samples according to 
the dominant genus. What was the rationale behind this 
method? As previously mentioned, no information exists 
in the publication on taxon annotation. Furthermore, 
there is no definition as to what determines “a dominant 
genus”; lastly why did the authors choose seven subtypes?
Despite the somewhat unclear nature of these seven 
subtypes, the authors further elaborate their analysis to 
report the ratio between those arbitrary seven subtypes 
as evidence for differences between endometriosis cases 
and controls. Instead, we would suggest that the authors 
applied a rigorous analysis, utilizing the raw sequenc-
ing data, to compare alpha and beta diversity metrics 
etc. between endometriosis cases and controls. In their 
first publication [2], interesting data was reported from 
qPCR analyses on the total abundance of Lactobacilli 
ascending from the vagina to the upper reproductive 
tract. That information would have been interesting also 
in the present publication. Finally, it has been shown that 
ascending infection is increased in patients with bacterial 
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vaginosis, OR 5.7 (95% CI, 1.8–18.3) [6]—could authors 
provide information on bacterial vaginosis status?
In summary—and in contrast to the importance state-
ment made by the authors—we find that the data analysis 
itself as well as the information level regarding the data 
analysis in the publication are not sufficient to answer the 
question whether a real microbiota of the upper genital 
tract exists and whether it is associated with endometrio-
sis. In our view and taking the current methods descrip-
tion into consideration, the conclusion of the study could 
also have been that upper genital tract samples were 
dominated by well-known contaminants which caused 
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